| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.042 | 0.8 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.036 | 0.8 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.038 | 0.8 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |